Association Between Adequate Serum 25(OH)D Levels and Atherogenic Dyslipidemia in Young Adults

Overview

Journal J Atheroscler Thromb

Date 2023 Dec 6

PMID 38057082

Authors

Ching-Way Chen

Yin-Yi Han

Jing-Shiang Hwang

Manfredi Rizzo

Shizuya Yamashita

Sandy Huey-Jen Hsu

Ta-Chen Su

Affiliations

Soon will be listed here.

Abstract

Aim: This study aimed to investigate the association between vitamin D deficiency and novel biomarkers of atherogenic dyslipidemia among young adults.

Method: A total of 976 young adults were recruited between 2011 and 2019. Their serum 25(OH)D levels were measured, and lipid profile markers, including low-density lipoprotein cholesterol (LDL-C), low-density lipoprotein triglyceride (LDL-TG), and small-dense low-density lipoprotein cholesterol (sdLDL-C), were assessed as novel biomarkers of atherogenic dyslipidemia. Multivariable linear regression was used to analyze the association between vitamin D levels and lipid profile markers. Odds ratios were calculated to assess the risk of atherogenic dyslipidemia in individuals with serum 25(OH)D levels below 30 ng/mL compared to those with levels above 30 ng/mL. Structural equation modeling (SEM) was employed to explore potential mediation pathways.

Results: The study found a significant association between vitamin D levels and lower levels of LDL-C, LDL-TG, sdLDL-C, non-high-density lipoprotein cholesterol (non-HDL-C), triglycerides, and total cholesterol. Individuals with serum 25(OH)D levels below 30 ng/mL exhibited significantly higher odds ratios for developing atherogenic dyslipidemia in a dose-response pattern compared to those with vitamin D levels above 30 ng/mL. Notably, structural equation modeling (SEM) analysis revealed that vitamin D did not affect atherogenic lipid markers through the mediation of insulin resistance markers or high-sensitivity C-reactive protein.

Conclusion: This study provides evidence of an association between vitamin D deficiency and atherogenic dyslipidemia in young adults. It further highlights that individuals with serum 25(OH)D levels below 30 ng/mL are at a significantly higher risk of developing atherogenic dyslipidemia in a dose-response manner compared to those with higher vitamin D levels. These findings underscore the potential role of vitamin D in dyslipidemia management and emphasize the importance of maintaining sufficient vitamin D levels for cardiovascular health in young adults.

Citing Articles

Association Between Decreased Serum Vitamin D Level and Dyslipidemia: A Cross-Sectional Study in Southern Taiwan.

Chou S, Loke S, Lan C, Sun C, Huang Y, Huang C Int J Gen Med. 2024; 17:4369-4376.

PMID: 39355338 PMC: 11444229. DOI: 10.2147/IJGM.S480241.

Prevalence and Causes of Vitamin D Deficiency in a Cohort of Greek HIV-Infected Individuals: A Prospective, Single Center, Observational Study.

Androutsakos T, Politou M, Boti S, Pittaras T, Kontos A, Kordossis T Curr HIV Res. 2024; 22(4):240-248.

PMID: 38874038 DOI: 10.2174/011570162X302844240605104855.

Vitamin D and Dyslipidemia: Is There Really a Link? A Narrative Review.

Al Refaie A, Baldassini L, Mondillo C, De Vita M, Giglio E, Tarquini R Nutrients. 2024; 16(8).

PMID: 38674837 PMC: 11053479. DOI: 10.3390/nu16081144.

The Importance of Preventing Vitamin D Deficiency.

Nakajima Y J Atheroscler Thromb. 2024; 31(5):520-521.

PMID: 38382994 PMC: 11079478. DOI: 10.5551/jat.ED257.

References

Xiao C, Dash S, Morgantini C, Hegele R, Lewis G . Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL Cholesterol. Diabetes. 2016; 65(7):1767-78. DOI: 10.2337/db16-0046. View

Lee J, OKeefe J, Bell D, Hensrud D, Holick M . Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?. J Am Coll Cardiol. 2008; 52(24):1949-56. DOI: 10.1016/j.jacc.2008.08.050. View

Berberich A, Hegele R . A Modern Approach to Dyslipidemia. Endocr Rev. 2021; 43(4):611-653. PMC: 9277652. DOI: 10.1210/endrev/bnab037. View

Takahashi S, Sakai J, Fujino T, Hattori H, Zenimaru Y, Suzuki J . The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor. J Atheroscler Thromb. 2004; 11(4):200-8. DOI: 10.5551/jat.11.200. View

Saeed A, Feofanova E, Yu B, Sun W, Virani S, Nambi V . Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease. J Am Coll Cardiol. 2018; 72(2):156-169. PMC: 6051722. DOI: 10.1016/j.jacc.2018.04.050. View

Bischoff-Ferrari H, Willett W, Wong J, Giovannucci E, Dietrich T, Dawson-Hughes B . Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA. 2005; 293(18):2257-64. DOI: 10.1001/jama.293.18.2257. View

Surdu A, Pinzariu O, Ciobanu D, Negru A, Cainap S, Lazea C . Vitamin D and Its Role in the Lipid Metabolism and the Development of Atherosclerosis. Biomedicines. 2021; 9(2). PMC: 7916166. DOI: 10.3390/biomedicines9020172. View

Verdoia M, Viglione F, Boggio A, Stefani D, Panarotto N, Malabaila A . Relationship between vitamin D and cholesterol levels in STEMI patients undergoing primary percutaneous coronary intervention. Nutr Metab Cardiovasc Dis. 2022; 32(4):957-964. DOI: 10.1016/j.numecd.2021.11.014. View

Zhou A, Hypponen E . Vitamin D deficiency and C-reactive protein: a bidirectional Mendelian randomization study. Int J Epidemiol. 2022; 52(1):260-271. PMC: 9908047. DOI: 10.1093/ije/dyac087. View

10.

Tonouchi R, Okada T, Abe Y, Kazama M, Kuromori Y, Yoshino Y . Subclass distribution of low-density lipoprotein triglyceride and the clustering of metabolic syndrome components in Japanese children. Pediatr Int. 2020; 63(6):664-670. DOI: 10.1111/ped.14490. View

11.

Roth G, Johnson C, Abajobir A, Abd-Allah F, Abera S, Abyu G . Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J Am Coll Cardiol. 2017; 70(1):1-25. PMC: 5491406. DOI: 10.1016/j.jacc.2017.04.052. View

12.

Pilz S, Trummer C, Theiler-Schwetz V, Grubler M, Verheyen N, Odler B . Critical Appraisal of Large Vitamin D Randomized Controlled Trials. Nutrients. 2022; 14(2). PMC: 8778517. DOI: 10.3390/nu14020303. View

13.

Guan C, Fu S, Zhen D, Li X, Niu J, Cheng J . Correlation of serum vitamin D with lipid profiles in middle-aged and elderly Chinese individuals. Asia Pac J Clin Nutr. 2020; 29(4):839-845. DOI: 10.6133/apjcn.202012_29(4).0020. View

14.

Pirro M, Manfredelli M, Helou R, Scarponi A, Schillaci G, Bagaglia F . Association of parathyroid hormone and 25-OH-vitamin D levels with arterial stiffness in postmenopausal women with vitamin D insufficiency. J Atheroscler Thromb. 2012; 19(10):924-31. DOI: 10.5551/jat.13128. View

15.

Cashman K . Vitamin D Deficiency: Defining, Prevalence, Causes, and Strategies of Addressing. Calcif Tissue Int. 2019; 106(1):14-29. DOI: 10.1007/s00223-019-00559-4. View

16.

Han Y, Hsu S, Su T . Association between Vitamin D Deficiency and High Serum Levels of Small Dense LDL in Middle-Aged Adults. Biomedicines. 2021; 9(5). PMC: 8145029. DOI: 10.3390/biomedicines9050464. View

17.

Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Kostenberger M, Tmava Berisha A . Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr. 2020; 74(11):1498-1513. PMC: 7091696. DOI: 10.1038/s41430-020-0558-y. View

18.

Forrest K, Stuhldreher W . Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res. 2011; 31(1):48-54. DOI: 10.1016/j.nutres.2010.12.001. View

19.

Gunzler D, Chen T, Wu P, Zhang H . Introduction to mediation analysis with structural equation modeling. Shanghai Arch Psychiatry. 2014; 25(6):390-4. PMC: 4054581. DOI: 10.3969/j.issn.1002-0829.2013.06.009. View

20.

Maestro B, Campion J, Davila N, Calle C . Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J. 2000; 47(4):383-91. DOI: 10.1507/endocrj.47.383. View